© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Chemical name: Prazosin Hydrochloride
Synonyms: Minipress Hydrochloride
Appearance: White or off-white crystalline powder
Intended use: Prescription medication for hypertension and other vascular issues
CAS Number: 19216-56-9
Acute effects: Inhalation or ingestion can reduce blood pressure excessively, cause dizziness, fainting, and rapid heartbeat. Eye, skin and respiratory tract irritation may develop from spills or poor handling.
Chronic exposure: Prolonged contact may interfere with cardiovascular system, potentially causing long-term health changes. There is a risk of hypotension and, in rare cases, priapism in individuals who handle or accidentally ingest large quantities.
Classification: Not classified as carcinogenic by major authorities, but may cause discomfort and significant physiological changes if mishandled.
Signal words: Warning for both immediate and delayed health effects.
Main component: Pure Prazosin Hydrochloride
Percentage: Higher than 98% as supplied for clinical or pharmaceutical use
Impurities: Pharmaceutical-grade compounds maintain impurities under 0.5% depending on the batch
Molecular formula: C19H21N5O4·HCl
Inhalation: Move from the area, get fresh air, and seek medical support if symptoms like lightheadedness, nausea, or palpitations occur.
Skin contact: Wash thoroughly with soap and water. Remove and launder contaminated clothing. Watch for irritation or unusual symptoms.
Eye contact: Rinse the eye with running water for several minutes. Monitor for ongoing irritation, pain, or reduced vision and visit a physician if symptoms persist.
Ingestion: Do not induce vomiting. Rinse mouth and contact a medical professional. Rapid medical assessment can prevent more significant health risks.
Extinguishing media: Dry chemical or carbon dioxide, as water spray may be less effective on pharmaceutical powders.
Combustion hazards: Toxic fumes including nitrogen oxides and carbon oxides may develop during burning or excessive heating.
Protection: Firefighters should use full protective gear including self-contained breathing apparatus due to the risk of hazardous dust or smoke.
Explosion risk: Fine powders may present a dust explosion hazard under exceptional conditions; minimize airborne concentration.
Personal precautions: Avoid respiratory and skin exposure. Wear disposable gloves, eye protection, and either a dust mask or respirator rated for fine powders.
Containment: Gently sweep up material without creating clouds. Do not let powder scatter or become airborne.
Environmental precautions: Prevent runoff into drains, soil, or waterways to avoid contamination of water sources and natural habitats.
Cleanup: Collect spilled powder in a sealed bag for safe disposal using wet methods or specialized vacuum equipment designed for pharmaceutical dusts.
Handling: Limit direct contact with the powder. Use local exhaust ventilation or work in a chemical fume hood. Prevent ingestion or inhalation by sticking to procedures. Avoid eating, drinking, or using personal products near work areas. Wash hands after handling.
Storage: Keep container tightly closed in a cool, dry, and well-ventilated place. Protect from direct sunlight and sources of heat. Segregate from incompatible chemicals such as oxidizers and strong acids.
Engineering controls: Chemical fume hoods or enclosed systems reduce risk during compound weighing and transfer.
Personal protective equipment: Nitrile gloves, safety goggles, and laboratory coats are typical for safe handling. Respirators may be needed if airborne dust forms.
Exposure limits: No occupational exposure limits have been set by major health and safety agencies, but pharmaceutical handling protocols suggest minimizing contact and inhalation.
Appearance: Crystalline, odorless powder
Solubility: Soluble in water and alcohol
Melting Point: Information from literature reports melting above 270°C
Stability: Chemically stable under normal conditions away from moisture, high heat, or acids.
pH of solution: Mildly acidic when dissolved in water
Chemical stability: Stable under recommended storage and handling conditions. Breakdown may occur under high temperature, mechanical impact, or in the presence of incompatible chemicals.
Reactivity: Do not mix with oxidizing agents, acids or bases as decomposition with generation of potentially harmful gases is possible.
Decomposition products: Nitrogen oxides, carbon oxides, and possibly hydrogen chloride under extreme heat.
Routes of entry: Inhalation, ingestion, skin absorption
Acute effects: Drowsiness, dizziness, headache, heart palpitations, and very low blood pressure.
Chronic effects: Long-term, repeated occupational exposure may contribute to hypotension, bradycardia, or other cardiovascular problems.
Sensitization: Not recognized as a skin sensitizer based on available reports.
Carcinogenicity: Not classified as carcinogenic according to IARC, NTP, or OSHA.
Aquatic toxicity: Active pharmaceutical ingredients can disrupt aquatic systems if released in volume. Drug residues may persist in water and impact fish or microorganisms.
Persistence: Degrades slowly in the environment. The potential for bioaccumulation exists but is considered low.
Mobility: Soluble in water; could move with surface runoff if released during cleaning or spills. Responsible waste management reduces this risk significantly.
Waste management: Unwanted product and contaminated materials should be collected and incinerated or sent to hazardous pharmaceutical waste processors. Flushing small amounts down the drain can result in environmental contamination and should be avoided.
Local regulations: Adhere to local and national disposal rules for prescription drug ingredients to prevent diversion or inappropriate landfill.
Shipping requirements: Transport in well-sealed packaging, labeled for pharmaceutical use.
Hazard classification: Not regulated as a dangerous good under standard chemical transport conventions for most countries.
Precautions: Secure against physical damage and moisture during shipping and handling.
Legal status: Prescription pharmaceutical, regulated under controlled substance or drug product rules in many countries.
Workplace safety: Occupational health standards for pharmaceutical plants and research facilities may require additional controls based on exposure potential.
Environmental protection: Increasing attention by regulatory agencies focuses on minimizing pharmaceutical pollution through stewardship in manufacturing, use, and disposal.
